{"id":791,"date":"2026-09-01T17:35:05","date_gmt":"2026-09-01T17:35:05","guid":{"rendered":"https:\/\/nhdbio.com\/resources\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/"},"modified":"2026-09-08T07:30:41","modified_gmt":"2026-09-08T07:30:41","slug":"melanotan-ii-human-pilot-toxicity-regulatory-evidence","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/pt-br\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","title":{"rendered":"Melanotan II: Dados do piloto humano, toxicidade e status regulat\u00f3rio"},"content":{"rendered":"

Melanotan II limitou os dados iniciais de exposi\u00e7\u00e3o humana e documentou os danos do uso n\u00e3o regulamentado. Um piloto de bronzeamento composto por tr\u00eas pessoas n\u00e3o pode superar os relat\u00f3rios de toxicidade posteriores ou os avisos atuais dos reguladores.<\/p>

Evid\u00eancias em resumo<\/h2>
  • O piloto cego 1996 inscreveu tr\u00eas volunt\u00e1rios saud\u00e1veis \u200b\u200bdo sexo masculino e usou solu\u00e7\u00e3o salina alternada ou dias Melanotan II.<\/li>
  • Com 0.03 mg\/kg, um dos dois participantes apresentou sonol\u00eancia e fadiga de grau II; n\u00e1useas e ere\u00e7\u00f5es espont\u00e2neas prolongadas tamb\u00e9m foram relatadas.<\/li>
  • Uma exposi\u00e7\u00e3o confirmada a mg de 6 em um homem de 39 anos de idade foi seguida por taquicardia, disfun\u00e7\u00e3o renal e CPK aumentando de 1,760 para 17,773 IU\/L.<\/li><\/ul><\/div><\/div>
    \"Revis\u00e3o
    Ilustra\u00e7\u00e3o editorial gerada por AI ilustrando o fluxo de trabalho da pesquisa. N\u00e3o se trata de figura de estudo, imagem de paciente, fotografia de produto, resultado de ensaio ou lote de cat\u00e1logo.<\/figcaption><\/figure>

    Registro de estudo<\/h2>

    O piloto da fase I foi concebido para observar efeitos a curto prazo e n\u00e3o para estabelecer a seguran\u00e7a da popula\u00e7\u00e3o. Tr\u00eas participantes s\u00e3o insuficientes para estimar eventos adversos incomuns, e o resultado n\u00e3o valida os produtos atuais da Internet.<\/p>

    Piloto 1996<\/strong>3 homens saud\u00e1veis; solu\u00e7\u00e3o salina alternada\/MT-II; 0.01 a 0.025\u20130.03 mg\/kg<\/span><\/div>
    Sinais piloto<\/strong>Pigmenta\u00e7\u00e3o em 2; n\u00e1usea, sonol\u00eancia\/fadiga e ere\u00e7\u00f5es relatadas<\/span><\/div>
    Caso 2012<\/strong>Homem de 39; 6 mg material adquirido pela Internet confirmado por espectrometria de massa<\/span><\/div>
    Pico CPK<\/strong>17,773 IU\/L \u00e0s horas 12<\/span><\/div>
    Limite regulat\u00f3rio<\/strong>FDA descreve Melanotan II como um novo medicamento n\u00e3o aprovado; TGA encontrou conte\u00fado inconsistente de produtos online<\/span><\/div><\/div><\/div>

    Resultados no contexto<\/h2>

    No caso de toxicologia 2012, a frequ\u00eancia card\u00edaca atingiu 146 batimentos por minuto, a creatinina foi de 2.25 mg\/dL, CPK posteriormente atingiu o pico de 17,773 IU\/L e o tratamento de terapia intensiva durou tr\u00eas dias. A espectrometria de massa confirmou Melanotan II em rela\u00e7\u00e3o a um padr\u00e3o, fortalecendo a atribui\u00e7\u00e3o de exposi\u00e7\u00e3o, permanecendo como um caso \u00fanico.<\/p>

    Em agosto 2026, o TGA da Austr\u00e1lia informou que cinco frascos de spray nasal apreendidos rotulados como 30 mg continham quantidades estimadas variando de 22 a 54 mg. Esta inconsist\u00eancia no mundo real \u00e9 um risco de qualidade do produto e de dosagem separado da farmacologia da mol\u00e9cula.<\/p>

    O que a evid\u00eancia n\u00e3o pode estabelecer<\/h2>

    A amostra piloto de tr\u00eas n\u00e3o pode estabelecer seguran\u00e7a ou efic\u00e1cia.<\/p>

    Um relato de caso n\u00e3o pode estimar a incid\u00eancia, mas pode documentar um evento grave plaus\u00edvel.<\/p>

    O conte\u00fado n\u00e3o regulamentado do produto n\u00e3o pode ser presumido a partir de um r\u00f3tulo, e os materiais de pesquisa do cat\u00e1logo n\u00e3o s\u00e3o medicamentos aprovados.<\/p>","protected":false},"excerpt":{"rendered":"

    Melanotan II limitou os dados iniciais de exposi\u00e7\u00e3o humana e documentou os danos do uso n\u00e3o regulamentado. Um piloto de bronzeamento composto por tr\u00eas pessoas n\u00e3o pode superar os relat\u00f3rios de toxicidade posteriores ou os avisos atuais dos reguladores.<\/p>","protected":false},"author":1,"featured_media":775,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"350","pim_article_type":"Published evidence review","pim_evidence_level":"Three-person phase I pilot, case reports and current regulatory safety warnings","pim_reviewer":"Site evidence editorial team","pim_reviewed_date":"2026-09-02","pim_editorial_note":"Source-checked on 2026-09-02. Null results, sample size, model\/population limits and regulatory scope are retained. This is not medical advice, a customer case or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"Primary and official sources, numerical results, null findings, limitations, product-evidence boundary and image disclosure checked for batch 4.","pim_creation_method":"This article discusses the source records listed below, with the study models and limitations stated alongside the findings. AI-assisted drafting and image generation were used. The reference list identifies the records behind this article; it is not an independent peer review or verification of a supplied catalog lot.","pim_sources":"[{\"title\":\"Melanotan II pilot phase I study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/8637402\/\",\"note\":\"Three-person single-blind pilot; PMID 8637402.\"},{\"title\":\"Melanotan II systemic toxicity and rhabdomyolysis\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23121206\/\",\"note\":\"Mass-spectrometry-confirmed case report; PMID 23121206.\"},{\"title\":\"TGA finds inconsistent Melanotan II content\",\"url\":\"https:\/\/www.tga.gov.au\/safety\/safety-monitoring-and-information\/safety-alerts\/melanotan-ii-tanning-peptide-products-found-be-inconsistently-dosed\",\"note\":\"Official August 2026 laboratory-testing safety alert.\"},{\"title\":\"FDA Melanotan II enforcement record\",\"url\":\"https:\/\/www.fda.gov\/regulatory-information\/electronic-reading-room\/notice-opportunity-hearing-nooh-manookian-edward-8516\",\"note\":\"Official record describing Melanotan II as an unapproved new drug.\"},{\"title\":\"PubChem Melanotan II record\",\"url\":\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/melanotan-II\",\"note\":\"Cyclic sequence, formula and molecular weight; CID 92432.\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-791","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"\nMelanotan II: Human Pilot Data, Toxicity and Regulatory Status<\/title>\n<meta name=\"description\" content=\"Melanotan II has limited early human exposure data and documented harms from unregulated use. A three-person tanning pilot cannot outweigh later toxicity r\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/pt-br\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status\" \/>\n<meta property=\"og:description\" content=\"Melanotan II has limited early human exposure data and documented harms from unregulated use. A three-person tanning pilot cannot outweigh later toxicity r\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/pt-br\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T17:35:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-08T07:30:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status\",\"datePublished\":\"2026-09-01T17:35:05+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\"},\"wordCount\":334,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-evidence.webp\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\",\"name\":\"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-evidence.webp\",\"datePublished\":\"2026-09-01T17:35:05+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"description\":\"Melanotan II has limited early human exposure data and documented harms from unregulated use. A three-person tanning pilot cannot outweigh later toxicity r\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-evidence.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-evidence.webp\",\"width\":1672,\"height\":941,\"caption\":\"AI-generated illustration: clinical-toxicology case review\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/pt-br\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Melanotan II: Dados do piloto humano, toxicidade e status regulat\u00f3rio","description":"Melanotan II limitou os dados iniciais de exposi\u00e7\u00e3o humana e documentou os danos do uso n\u00e3o regulamentado. Um piloto de bronzeamento composto por tr\u00eas pessoas n\u00e3o pode compensar os riscos de toxicidade posteriores\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/pt-br\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","og_locale":"pt_BR","og_type":"article","og_title":"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status","og_description":"Melanotan II has limited early human exposure data and documented harms from unregulated use. A three-person tanning pilot cannot outweigh later toxicity r\u2026","og_url":"https:\/\/nhdbio.com\/pt-br\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","og_site_name":"NHD","article_published_time":"2026-09-01T17:35:05+00:00","article_modified_time":"2026-09-08T07:30:41+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status","datePublished":"2026-09-01T17:35:05+00:00","dateModified":"2026-09-08T07:30:41+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/"},"wordCount":334,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","articleSection":["Published Study Reviews"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","url":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","name":"Melanotan II: Dados do piloto humano, toxicidade e status regulat\u00f3rio","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","datePublished":"2026-09-01T17:35:05+00:00","dateModified":"2026-09-08T07:30:41+00:00","description":"Melanotan II limitou os dados iniciais de exposi\u00e7\u00e3o humana e documentou os danos do uso n\u00e3o regulamentado. Um piloto de bronzeamento composto por tr\u00eas pessoas n\u00e3o pode compensar os riscos de toxicidade posteriores\u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","width":1672,"height":941,"caption":"AI-generated illustration: clinical-toxicology case review"},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Mat\u00e9rias-primas pept\u00eddicas e s\u00edntese personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipe T\u00e9cnica NHD","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"A equipe t\u00e9cnica NHD mant\u00e9m documenta\u00e7\u00e3o de cat\u00e1logo de uso em pesquisa e resumos de evid\u00eancias. Os artigos revisados \u200b\u200bvinculam-se a artigos revisados \u200b\u200bpor pares, registros de ensaios e registros regulat\u00f3rios, ret\u00eam resultados nulos e limita\u00e7\u00f5es de estudos e distinguem interven\u00e7\u00f5es publicadas de materiais de cat\u00e1logo. O desenho assistido por AI pode ser usado para estrutura; os links de origem e os limites das evid\u00eancias permanecem vis\u00edveis. Este trabalho n\u00e3o \u00e9 uma revis\u00e3o independente por pares ou aconselhamento m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/pt-br\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/comments?post=791"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/791\/revisions"}],"predecessor-version":[{"id":1196,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/791\/revisions\/1196"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/media\/775"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/media?parent=791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/categories?post=791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/tags?post=791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}